• 792 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Phase I cancer clinical trials, breast cancer, gastrointestinal cancer.

Areas of Clinical Interest

Phase 1 clinical trials, GI/esophageal cancer.

Fingerprint Dive into the research topics where Haeseong Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 792 Citations
  • 25 Article
  • 2 Review article
  • 1 Chapter
  • 1 Comment/debate

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study

Modi, S., Park, H., Murthy, R. K., Iwata, H., Tamura, K., Tsurutani, J., Moreno-Aspitia, A., Doi, T., Sagara, Y., Redfern, C., Krop, I. E., Lee, C., Fujisaki, Y., Sugihara, M., Zhang, L., Shahidi, J. & Takahashi, S., Jun 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 17, p. 1887-1896 10 p.

Research output: Contribution to journalArticle

Open Access
  • 15 Scopus citations

    FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial

    Park, H., Jin, R. U., Wang-Gillam, A., Suresh, R., Rigden, C., Amin, M., Tan, B. R., Pedersen, K. S., Lim, K. H., Trikalinos, N. A., Acharya, A., Copsey, M. L., Navo, K. A., Morton, A. E., Gao, F. & Lockhart, A. C., 2020, (Accepted/In press) In : JAMA oncology.

    Research output: Contribution to journalArticle

  • Gastric cancer with radiographically occult metastatic disease: Biology, challenges, and diagnostic approaches

    Sanjeevaiah, A., Park, H., Fangman, B. & Porembka, M., Mar 2020, In : Cancers. 12, 3, 592.

    Research output: Contribution to journalReview article

    Open Access
  • Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer

    Chen, B., Alvarado, D. M., Iticovici, M., Kau, N. S., Park, H., Parikh, P. J., Thotala, D. & Ciorba, M. A., Apr 1 2020, In : Cancer immunology research. 8, 4, p. 451-464 14 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations